Guaifenesin

Description

The product identified by SPL Code 34089-3 is indicated for mucus relief. It is formulated to alleviate symptoms associated with excessive mucus production.

Uses and Indications

This drug is indicated for the relief of cough associated with respiratory tract conditions characterized by the presence of thick mucus. It helps to loosen phlegm and thin bronchial secretions, thereby facilitating more productive coughs to clear the bronchial passageway of bothersome mucus.

Limitations of Use: This medication is not intended for the treatment of cough due to smoking, asthma, or emphysema.

Dosage and Administration

Adults and children 12 years of age and older are instructed to take 1 caplet every 4 hours with a full glass of water, as needed while symptoms persist. It is imperative that the total dosage does not exceed 6 caplets within a 24-hour period.

The use of this medication is not recommended for children under 12 years of age.

Contraindications

There are no specific contraindications identified for this product. However, it is essential to adhere to the following guidelines to ensure safe use:

• Do not exceed the recommended dosage, as this may lead to adverse effects.

• Do not use the product for more than 7 days to avoid potential complications associated with prolonged use.

Warnings and Precautions

Healthcare professionals should exercise caution when recommending this product. It is imperative to consult a physician prior to use in patients with a persistent or chronic cough, particularly those associated with smoking, asthma, chronic bronchitis, or emphysema. Additionally, patients presenting with a cough accompanied by excessive phlegm (mucus) should also seek medical advice before using this product.

When administering this product, it is crucial to adhere to the recommended dosage guidelines. Exceeding the recommended dosage or using the product for more than 7 consecutive days is not advised, as this may lead to adverse effects.

In the event of an accidental overdose, immediate medical assistance should be sought. Healthcare professionals should instruct patients to contact a Poison Control Center at 1-800-222-1222 without delay.

Patients should be advised to discontinue use and consult a physician if their cough persists for more than 7 days, recurs, or is accompanied by additional symptoms such as fever, rash, or a persistent headache. These symptoms may indicate a more serious underlying condition that requires further evaluation and intervention.

Side Effects

Patients should discontinue use and consult a healthcare professional if a cough persists for more than 7 days, recurs, or is accompanied by fever, rash, or a persistent headache, as these symptoms may indicate a serious underlying condition.

Before initiating treatment, patients are advised to seek medical advice if they have a persistent or chronic cough associated with smoking, asthma, chronic bronchitis, or emphysema. Additionally, a cough accompanied by excessive phlegm (mucus) warrants consultation with a healthcare provider prior to use.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Mucus Relief. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. For adolescents aged 12 years and older, the recommended dosage is 1 caplet every 4 hours with a full glass of water, while symptoms persist. The maximum allowable dosage is 6 caplets in a 24-hour period.

It is essential to keep this medication out of reach of children. In the event of an accidental overdose, immediate medical assistance should be sought, or contact a Poison Control Center at 1-800-222-1222.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients should consult a healthcare professional prior to using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully understood. It is essential for women of childbearing potential to discuss their individual circumstances with their healthcare provider to weigh the benefits and risks associated with the use of this medication during pregnancy.

Lactation

Lactating mothers are advised to consult a healthcare professional prior to using this medication. There is currently no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of guidance necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an accidental overdose, it is imperative to seek immediate medical assistance. Healthcare professionals are advised to contact a Poison Control Center at 1-800-222-1222 for guidance on managing the situation effectively.

Prompt intervention is crucial to mitigate potential adverse effects associated with overdose. Symptoms may vary depending on the substance involved, and healthcare providers should be prepared to assess and manage these symptoms accordingly.

Management procedures may include supportive care and symptomatic treatment, tailored to the specific clinical presentation of the patient. Continuous monitoring and evaluation are essential to ensure patient safety and to address any complications that may arise during the course of treatment.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 in the event of an accidental overdose. It is important for patients to be aware that they should discontinue use and consult a doctor if their cough persists for more than 7 days, recurs, or is accompanied by symptoms such as fever, rash, or a persistent headache, as these may indicate a serious underlying condition.

Patients should be instructed not to exceed the recommended dosage while using this product and to limit its use to no more than 7 days. Additionally, healthcare providers should encourage patients to consult a doctor prior to use if they have a persistent or chronic cough associated with conditions such as smoking, asthma, chronic bronchitis, or emphysema. Furthermore, patients should be advised to seek medical advice if their cough is accompanied by excessive phlegm (mucus).

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It is recommended to store the product at a controlled room temperature of 25°C (77°F), with permissible excursions between 15°C to 30°C (59°F to 86°F).

To ensure the integrity of the product, it should be kept in a dry place, away from heat sources. Proper handling and storage conditions are crucial to maintain the product's efficacy and safety.

Additional Clinical Information

Adults and children aged 12 years and older are advised to take 1 caplet every 4 hours with a full glass of water while symptoms persist, ensuring that the total does not exceed 6 doses in a 24-hour period. The use of this medication is not recommended for children under 12 years of age. No further information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Mucus Relief, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)